shortagewatch

Home / Companies / Sun Pharma

Company family · HQ IN

Sun Pharma: medicine shortages

SUNPHARMA · NSE

As of 2 Nov 2026, 250 Sun Pharma products have a reported shortage across 10 countries, covering 77 medicines.

Products short250rank #10 of 464
Medicines77active ingredients
Countries10/16
New in 90 days25-7 vs market pace
Typical duration14 monthsmedian so far
Manufacturing55%demand-driven 17%

Where

United States21Canada48Germany88Italy59Spain8Ireland1Czechia2Norway3Sweden8Japan12

Which therapeutic classes

Nervous system58Cardiovascular system55Digestive tract and metabolism33Cancer and immune system31Dermatologicals21Anti-infectives19Systemic hormones10Genito-urinary system and sex hormones9Respiratory system3Sensory organs3

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated
Sun PharmaSun Pharma: Manufacturing problem 122 (49%)49%Sun Pharma: Increased demand 37 (15%)15%Sun Pharma: Active ingredient shortage 32 (13%)13%Sun Pharma: Commercial decision or withdrawal 1 (0%)Sun Pharma: Other 31 (12%)12%Sun Pharma: Not stated 27 (11%)11%All companiesAll companies: Manufacturing problem 4,893 (36%)36%All companies: Increased demand 1,873 (14%)14%All companies: Active ingredient shortage 367 (3%)All companies: Distribution or logistics 336 (2%)All companies: Commercial decision or withdrawal 435 (3%)All companies: Regulatory or licensing 131 (1%)All companies: Other 1,244 (9%)9%All companies: Not stated 4,221 (31%)31%

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes
DateCountryMedicineChange
1 NovDEOlanzapine
OLANZAPIN BASICS 7,5 mg Tabletten		resolved

Open shortages over time

10210310410531 Oct2026-10-31: 1041 Nov2026-11-01: 1032 Nov2026-11-02: 103

Products short per day in the 5 countries tracked since 31 Oct 2026, from our daily snapshots. The history lengthens every day.

When its current shortages began

05101520Dec: 4Jan ’25: 3Feb: 3FebMar: 2Apr: 0May: 15MayJun: 2Jul: 9Aug: 3AugSep: 7Oct: 6Nov: 15NovDec: 8Jan ’26: 6Feb: 10FebMar: 9Apr: 20May: 4MayJun: 7Jul: 8Aug: 11AugSep: 6Oct: 9Nov: 0Nov

Long-run trend in Canada

Canada dashboard
0621251872502017: 7820172018: 10020182019: 25020192020: 20420202021: 10420212022: 17220222023: 9920232024: 11820242025: 18820252026: 962026

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Viatris995Teva903Sandoz599Pfizer491Accord (Intas)484Stada349Zentiva340Fresenius Kabi339Apotex326Sun Pharma250Aurobindo226Towa (Pensa)201Krka187Sanofi158Jamp151

Breadth vs depth

1101001,00010,0001101001,000Products short (log scale)Medicines affected (log scale)Viatris: 995 / 248ViatrisTeva: 903 / 289TevaSandoz: 599 / 198SandozPfizer: 491 / 122PfizerAccord (Intas): 484 / 151Accord (Intas)Stada: 349 / 140Zentiva: 340 / 159ZentivaFresenius Kabi: 339 / 81Apotex: 326 / 152Aurobindo: 226 / 111Towa (Pensa): 201 / 102Krka: 187 / 67Sanofi: 158 / 45Jamp: 151 / 74Baxter: 149 / 27Sawai: 148 / 68Hikma: 126 / 44Glenmark: 105 / 39Sanis: 98 / 54Cheplapharm: 86 / 28GSK: 85 / 38Advanz (Amdipharm): 81 / 24Nichi-Iko: 77 / 29Takeda: 76 / 10Johnson & Johnson: 75 / 19Neuraxpharm: 75 / 19Novartis: 70 / 32Bayer: 68 / 17Biomed: 64 / 21Daiichi Sankyo: 59 / 18Orifarm: 59 / 40Medochemie: 56 / 14Pharmascience: 51 / 32Marcan: 51 / 16Doc Generici: 50 / 25B. Braun: 49 / 17AA Pharma: 46 / 26H E: 46 / 15Octapharma: 42 / 6Jv E: 42 / 1Kyowa Pharmaceutical: 42 / 16Novo Nordisk: 41 / 8Odan: 41 / 31Aspen: 41 / 13Sterop: 41 / 16Nipro: 41 / 17Dr. Reddy's: 40 / 24Organon: 40 / 20Laboratoire Riva: 40 / 23Kern Pharma: 40 / 30Bausch Health: 39 / 30Bracco: 38 / 6G.L.: 38 / 13Tatsumi Kagaku: 38 / 24Otsuka: 37 / 4Eli Lilly: 37 / 12Piramal Critical: 35 / 13Imuna Pharm: 35 / 4AbbVie: 34 / 15Medical Valley: 34 / 8Orion: 34 / 24Rowex: 34 / 19Takata Pharmaceutical: 33 / 17Aristo: 32 / 16Norgine: 32 / 3Gedeon Richter: 31 / 11Eql: 31 / 9Guerbet: 30 / 5Lukas Heil-Betriebsst: 30 / 0Roche: 29 / 14Omega: 29 / 18Bgp: 29 / 18Holsten -: 29 / 3Menarini: 29 / 17Paladin: 28 / 17Grifols: 28 / 9Ge: 28 / 6Merck & Co. (MSD): 27 / 14Ferring: 27 / 7Sun Pharma: 250 / 77Sun Pharma

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV
MedicineWhere this company is shortProductsEarliest startMain reasonShort anywhere
Esomeprazole1622 May 2025Manufacturing problem9/16
Candesartan1411 Feb 2025Active ingredient shortage10/16
Lisdexamfetamine1314 Jul 2023Other5/16
Pantoprazole135 Apr 2024Manufacturing problem9/16
Valsartan and Diuretics111 Jul 2018Other7/16
Lenalidomide92 Jul 2026Manufacturing problem10/16
Risperidone914 Feb 2024Manufacturing problem13/16
Simvastatin and Ezetimibe97 Jul 2022Other8/16
Isotretinoin811 Oct 2025Manufacturing problem4/16
Levetiracetam81 Jan 2025Active ingredient shortage9/16
Octreotide714 Jul 2025Not stated6/16
Atosiban616 Jul 2021Not stated5/16
Olanzapine622 May 2025Manufacturing problem13/16
Pemetrexed620 Jul 2022Manufacturing problem6/16
Valsartan619 Mar 2026Manufacturing problem7/16
Gemcitabine55 Jan 2024Manufacturing problem9/16
Atorvastatin44 Aug 2025Active ingredient shortage11/16
Ciprofloxacin41 Jul 2025Manufacturing problem9/16
Desvenlafaxine43 Nov 2025Manufacturing problem1/16
Temozolomide413 Feb 2026Increased demand6/16
Budesonide314 Apr 2022Manufacturing problem4/16
Cefaclor31 Dec 2025Manufacturing problem4/16
Pregabalin311 Feb 2026Manufacturing problem11/16
Acitretin215 Sep 2023Manufacturing problem2/16
Amlodipine21 Sep 2024Manufacturing problem8/16
Bosentan231 May 2022Increased demand7/16
Buprenorphine221 Feb 2022Increased demand4/16
Carbamide26 Dec 2024Other2/16
Cetrorelix220 May 2025Manufacturing problem3/16
Citalopram219 Oct 2023Increased demand5/16
Clarithromycin215 Mar 2022Increased demand5/16
Ertapenem218 Jul 2025Manufacturing problem4/16
Luliconazole210 Feb 2026Increased demand1/16
Maprotiline22 Jun 2026Increased demand2/16
Meropenem27 Jun 2024Manufacturing problem6/16
Nadifloxacin26 Dec 2024Other1/16
Nystatin224 Jun 2026Active ingredient shortage1/16
Pindolol230 Jan 2026Not stated2/16
Sitagliptin212 May 2024Manufacturing problem8/16
Tobramycin230 Apr 2024Manufacturing problem5/16
Trabectedin227 Feb 2026Not stated6/16
Venlafaxine213 Apr 2026Manufacturing problem10/16
Abiraterone120 Mar 2025Increased demand7/16
Bortezomib11 Dec 2023Manufacturing problem5/16
Carbamazepine124 Jun 2024Manufacturing problem5/16
Caspofungin14 Aug 2026Increased demand5/16
Cefuroxime11 Apr 2026Manufacturing problem5/16
Ciclopirox11 Aug 2025Manufacturing problem3/16
Clobetasol120 Jan 2026Manufacturing problem2/16
Clotrimazole117 Jun 2026Manufacturing problem2/16
Deferasirox12 Jul 2025Manufacturing problem8/16
Dexamethasone and Antiinfectives14 Mar 2026Manufacturing problem2/16
Donepezil119 Oct 2023Increased demand8/16
Entecavir18 Aug 2022Increased demand8/16
Escitalopram115 Dec 2023Manufacturing problem10/16
Estradiol119 Oct 2026Increased demand11/16
Fampridine11 Sep 2026Manufacturing problem2/16
Hydralazine121 Nov 2025Other5/16
Irinotecan120 May 2025Manufacturing problem5/16
Lamivudine and Abacavir128 Jul 2025Manufacturing problem2/16
Latanoprost126 Oct 2026Manufacturing problem4/16
Liraglutide128 Oct 2026Not stated4/16
Lurasidone11 Jul 2026Manufacturing problem2/16
Melphalan19 Sep 2022Increased demand4/16
Omeprazole131 Jan 2023Manufacturing problem8/16
Oxaliplatin11 Oct 2026Increased demand10/16
Ramipril13 Dec 2025Manufacturing problem10/16
Ramipril and Diuretics111 Mar 2026Manufacturing problem4/16
Riluzole131 Dec 2022Manufacturing problem6/16
Rosuvastatin131 Dec 2023Increased demand12/16
Simvastatin15 Aug 2026Manufacturing problem9/16
Terbinafine121 Oct 2025Increased demand5/16
Terlipressin130 Apr 2024Manufacturing problem1/16
Testosterone127 Aug 2026Manufacturing problem3/16
Tetrabenazine131 Oct 2022Manufacturing problem1/16
Timolol, Combinations131 Oct 2026Commercial decision or withdrawal9/16
Tizanidine115 Jul 2025Manufacturing problem4/16

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.